Darshan offentlig
[search 0]
Mer
Download the App!
show episodes
 
Businesses thrive by knowing customer insights, because today’s insights are tomorrow's facts. At iResearch we live and breathe insights. And despite searching high and low, we were unable to find a customer insights podcast that answers one of the most important questions in business: why do customers do what they do? So we launched one.
  continue reading
 
Artwork
 
Welcome to DarshanTalks! We demystify fraud for legal, regulatory, and compliance essentials in the life sciences and pharmacy industries. Through engaging 15-30-minute interviews with influential change makers, short educational regulatory defbriefs, and 60 second audio takeaways, we unveil the strategies behind bringing drugs and devices to market—and keeping them there! Powered By The Kulkarni Law Firm - Helping regulators see your business the way you do. We focus on life science issues ...
  continue reading
 
Artwork

1
Sailesh Darshan

Sailesh Chand Darshan

Unsubscribe
Unsubscribe
Daglig+
 
Sharing my life stories, experiences, and motivational teachings and wisdom. Early in my life I survived a life threatning illness where I was given no chance to live more the 6 months. That was 26 years ago....... Cover art photo provided by Oleg Laptev on Unsplash: https://unsplash.com/@snowshade
  continue reading
 
Artwork

1
Sri Birendra Darshan

Sri Birendra Darshan

Unsubscribe
Unsubscribe
Månedlig
 
Sri Birendra Chandra Chakraborty, His Excellency was well known to the general mass as Param Pita Janmasiddyha Thakur Sri Sri Balak Brahmachari Maharaj. Sri Sri Thakur's disciples, devotees, followers and impassioned counts to 25 Crores in India itself. During his tenure, many great men of different name and fame from various castes, creeds and sects of the society had the opportunity to seek His blessings.The Great Hymn “RAM NARAYAN RAM” was given by Sri Sri Thakur which is the revamp of “H ...
  continue reading
 
Loading …
show series
 
In this Greatest Hits episode of Getting to Aha!, host Darshan Mehta is joined by Gil Eyal, the Head of Marketing and Innovation at Silverstein Properties. Their conversation delves into Gil’s transformative “aha!” moments, contrasting influencer marketing with celebrity endorsements, avoiding common pitfalls in celebrity endorsements, and highligh…
  continue reading
 
Darshan was asked to explain why drug names can be so complicated, and the answer lies in the fact that each drug typically has at least three distinct names. First, there’s the chemical name, which is a technical identifier describing the drug’s molecular structure—these names are often long and complex, like “acetylsalicylic acid,” and are more f…
  continue reading
 
In this episode, Istvan Fekete joins us to discuss the intricacies of Congruency Reviews. We will explore the common mistakes individuals may encounter during these reviews and examine effective strategies for handling these errors. Additionally, we will delve into the processes that can be implemented to mitigate risks associated with congruency r…
  continue reading
 
In this episode of Getting to Aha!, Darshan Mehta is joined by @Marc Kerachsky, CMO of AMC Health. Marc has over 32 years of experience in healthcare. Join them as they discuss the power of storytelling in organizations and how it can build trust, improve communication, and foster empathy within teams. Marc shares his journey and aha moments, empha…
  continue reading
 
Today, we're discussing a critical issue for pharmaceutical and medical device marketers – promotional compliance. Overview of the Innovasis Settlement: Innovasis Inc. recently settled a $12 million case for alleged kickback schemes to doctors. This highlights the importance of promotional compliance. Allegations Against Innovasis: From Jan. 1, 201…
  continue reading
 
Darshan addresses common questions about potential treatments for hair loss. He provides insights based on his expertise as both a pharmacist and an FDA regulatory lawyer. Darshan explains that FDA-approved treatments for hair loss include minoxidil and finasteride. Minoxidil, originally a blood pressure medication, can lower blood pressure and has…
  continue reading
 
In this Greatest Hits episode of Getting to Aha!, Darshan talks with John Zogby, Senior Partner at John Zogby Strategies, a marketing and political consulting firm offering opinion research services. John has served as an election analyst for networks like ABC Australia, BBC, CBC, and NBC News. Together, they explore how John became involved in pol…
  continue reading
 
Today's discussion revolves around the legal clauses found in clinical trials, with a focus on Article 8, the Publication Rights Clause. The following points are discussed: Unrestricted Rights: The clause prov ides the Site with unrestricted rights to publish all trial data. This is excessive and could jeopardize the Sponsor's control over the inte…
  continue reading
 
We discuss the seven ways pharmacy investigations can begin: 1. Data Analysis: Agencies like the DEA and DOJ monitor prescription data for unusual patterns, such as excessive dispensing of certain drugs. 2. Tips: Anonymous reports from the public or industry insiders alert authorities to suspicious activities. 3. Whistleblowers: Individuals within …
  continue reading
 
In this episode of Getting to Aha!, Darshan Mehta is joined by Rick Denton, Managing Principal at EX4CX. Join them as they discuss how businesses can improve customer experience by leveraging feedback and data, the importance of combining process improvement with a customer-centric approach, and the alignment of customer experience (CX) efforts wit…
  continue reading
 
In this ‘Greatest Hits’ episode of Getting to Aha!, host Darshan Mehta is joined by Stephen Griffiths, Director of Insights & Strategy at Post Consumer Brands. You’ll learn why, when gathering data, you must strike a balance between qualitative and quantitative data, get the lowdown on why insights need to be broader than just market research, and …
  continue reading
 
In this episode of Getting to Aha!, Darshan Mehta is joined by Millie Tadewaldt, the founder and CEO of Brilliant. Join them as they discuss personalized corporate gifting, the need for technology in the gifting process, and the measurement of ROI. Millie Tadewaldt is the founder and CEO of Brilliant, a company specializing in personalized corporat…
  continue reading
 
Subscriber-only episode We dive into the critical issue of racial bias in AI, highlighted by a recent Yale study focusing on ChatGPT. This has significant implications for clinical research sponsors, sites, and principal investigators. We also explore the FDA's perspective on AI in clinical trials, presented by Dr. Elzarrad. Overview of the Yale St…
  continue reading
 
Today we're diving into a critical issue that has shaken the pharmacy world. Recently, a pharmacy owner was sentenced for paying illegal kickbacks and engaging in a money laundering conspiracy. This case has significant implications for promotional compliance within the pharmacy industry, and we're here to explore them in detail. In a landmark case…
  continue reading
 
In this ‘Greatest Hits’ episode of Getting to Aha!, host Darshan Mehta is joined by Andrew Custage, Senior Director and Head of Insights at Medallia Market Research. Join them as they discuss striking a balance between qualitative and quantitative data, customizing survey questions, and differentiating between active customers and inactive customer…
  continue reading
 
Today, we're diving into the FDA's Fiscal Year 2022 report on postmarketing requirements (PMRs) and postmarketing commitments (PMCs). PMRs are mandatory studies required by the FDA after a drug's approval, focusing on real-world data for long-term safety and effectiveness. Think of them as an extension of the initial research phase, but in a real-w…
  continue reading
 
Do dietary supplements interact with drugs? Many people think only prescription drugs can cause interactions, but dietary supplements can too. From an FDA perspective, a drug is defined by its claims and indications. Some supplements make drug-like claims and can interact with medications. Common examples include grapefruit juice and vitamin K, whi…
  continue reading
 
In this episode of @Getting to Aha!, @Darshan Mehta is joined by @Lisa Curtis, founder and CEO of Kuli Kuli Foods. Join them as they discuss Lisa's journey in promoting nutritious and sustainable food products, the challenges of sourcing high-quality ingredients, and her commitment to paying it forward. Lisa is the founder and CEO of Kuli Kuli Food…
  continue reading
 
In today's consumer landscape, privacy concerns reign supreme. Pharmaceutical and medical device manufacturers must prioritize meeting the expectations of this privacy-conscious generation. This begins with three key measures: 1. Consent Management: Clear communication about data usage is essential, aligning with regulations like CCPA and GDPR. See…
  continue reading
 
Edye Edens, a consultant and attorney with a background in regulatory affairs, shared insights into her unexpected yet exciting role at Weave, a rapidly growing startup specializing in AI-driven solutions for regulatory content creation. Edye discussed her journey from freelance consultancy to joining Weave, highlighting the unique challenges and o…
  continue reading
 
In this ‘Greatest Hits’ episode of Getting to Aha!, host Darshan Mehta is joined by Sanjai George, CEO of Double Horse. Join them as they discuss effective communication and simplicity in retail, the value of adapting to the changing retail landscape, and why customer feedback is so important. Sanjai also discusses the changes and trends that have …
  continue reading
 
In this episode, we discuss how drug and device manufacturers may seem to collaborate with telemedicine companies to market products and ensure patient needs are met conveniently. However, there are three major concerns: 1. Ignoring Pharma Laws: Telehealth companies might not adhere to pharma marketing laws and could act as agents for pharma due to…
  continue reading
 
Today, we're tackling a critical issue for restaurants and food marketers: promotional compliance and the risks of misbranding, as highlighted by a recent case in Biloxi. Mary Mahoney's Old French House Restaurant and its co-owner, Anthony Charles Savanovich, recently pled guilty to conspiracy and misbranding seafood. Over six years, they sold over…
  continue reading
 
In this episode of @Getting to Aha!, Darshan Mehta is joined by Greg Segal, a writer/director and producer. Join them as they discuss Greg's journey from lawyer to filmmaker, the value of contemplating life choices, and his involvement in producing vertical movies for platforms like TikTok. Greg Segal is a writer/director and producer based in New …
  continue reading
 
We discuss how the shortage of chemotherapy drugs stems from economic challenges faced by generic drug manufacturers. Many cannot afford to produce these drugs due to low profitability. Factors include factory shutdowns for quality issues, a complex global supply chain, and older generic drugs being unprofitable to produce. Government pressure on p…
  continue reading
 
In this episode, Daniel Fox discusses the key challenges faced by research sites, including trust issues, payment delays, and operational setbacks. He emphasizes initiatives like the "Open Mic" policy for anonymous feedback and the grassroots movement Save Our Sites (SOS). Dr. Fox also explores issues with decentralized clinical trials, advocates f…
  continue reading
 
In this ‘Greatest Hits’ episode of Getting to Aha!, host Darshan Mehta is joined by Steve Sidelnyk, highly accomplished session drummer and music programmer, and Jim Turner, an experienced entertainment industry professional. Join them as they discuss the importance of standing out in a competitive industry, the importance of curiosity and learning…
  continue reading
 
In clinical trials, reporting adverse events and protocol deviations is crucial for patient safety and trial integrity. However, some sites may hesitate to report due to concerns about trial disruption, revenue loss, and increased scrutiny. This reluctance can lead to serious consequences, as seen in cases where significant events like hives, disru…
  continue reading
 
In this episode, we delved into the pivotal role of patient advocates within the pharmaceutical industry. Patient advocates are champions who ensure that patients' voices are not only heard but also central to decisions affecting their health. They play a crucial role in various aspects: Firstly, patient advocates are instrumental in representing t…
  continue reading
 
In this episode of Getting to Aha!, Darshan Mehta is joined by Alan Versteeg, Global Chief Revenue Officer at Growth Matters. Join them as they discuss conveying customer value, the use of generative AI, and the role of empathy in sales. Alan also touches on the future of sales, and the role of sales managers. Alan Versteeg is an engineer turned sa…
  continue reading
 
Drug accountability is a critical aspect monitored by the FDA at clinical trial sites. Principal investigators must maintain and document control over investigational products, ensuring they are only administered under direct supervision. Clinical research organizations also conduct routine audits to verify drug accountability. However, instances o…
  continue reading
 
We discuss how to address drug shortages. First things first, it's important to stay calm. Just because there's a shortage doesn't mean you'll lose access to your medication entirely. Here are some action steps you can take: 1. Schedule an appointment with your doctor to discuss alternative medications that might be effective for you. It's crucial …
  continue reading
 
We discuss the risks associated with using AI in your pharma marketing plans: 1. Data Privacy and Security: Ensuring the security and privacy of data, whether it pertains to patients or non-patients, is paramount. 2. Bias: Questions arise regarding the sources of information, control over data, and addressing privacy concerns to prevent biases and …
  continue reading
 
In this episode, we discussed eight essential strategies to prevent prescription drug fraud and abuse: Verify the prescriber's identity. Know the prescriber's DEA number. Know your patient thoroughly. Verify prescription dates for validity; ensure prescriptions are current. Communicate directly with prescribers if any concerns arise. Request identi…
  continue reading
 
In this ‘Greatest Hits’ episode of Getting to Aha!, host Darshan Mehta is joined by Brandon Rhoten, Chief Marketing Officer at GroundTruth. Join them as they discuss the impact of social media in humanizing brands, why digital marketing channels should be seen as tools to solve specific brand problems, and leveraging customer insights beyond surfac…
  continue reading
 
In this episode we're joined by Heather McFalls, Director of Promotion Compliance at Otsuka Pharmaceutical Companies to discuss the evolving role of ad promo executives and the regulatory landscape in the pharmaceutical industry. Dive into the conversation as we explore the impact of regulatory bodies like the FDA, FTC, and NAD, and the importance …
  continue reading
 
Today, we discuss four legal pathways to acquire unapproved drugs. First, over-the-counter drugs offer a route as some bypass FDA approvals, relying instead on a nomograph. Second, compounded drugs crafted by pharmacists provide an alternative despite lacking FDA approval. Third, the FDA's new policy allows for state-imported drugs, provided certai…
  continue reading
 
In this episode of Getting to Aha!, Darshan Mehta is joined by Steve Bigari, the EVP, AI for Restaurants at Soundhound. Join them as they discuss how technology, particularly AI, can enhance the restaurant experience, the mindset needed to be a disruptor in the industry, and the importance of removing friction from the customer's life. Steve also s…
  continue reading
 
We discuss the essential elements to ensure that your pharma marketing plan aligns with AI use: 1. Define Clear Goals: Establishing clear objectives is crucial for developing a comprehensive compliance plan for AI use. Without clear goals, executing a successful strategy becomes challenging. 2. Establish Policies and Procedures: Clearly defined pol…
  continue reading
 
In this short, we explore four key reasons to get involved in clinical research. First, it offers potential access to cutting-edge therapies, though it's important to note you might only receive the standard of care. Second, participation ensures closer monitoring by healthcare professionals. Third, it provides an opportunity to contribute to medic…
  continue reading
 
In today’s episode, our guest is Andrew Stein, a partner in the healthcare department at Stevens and Lee . Darshan and Andrew discuss MedSpas. MedSpas combine beauty treatments with medical procedures, blurring the lines between pampering and healthcare. To navigate this complexity, they talk about MSOs, which are basically middlemen. MSOs let non-…
  continue reading
 
In this ‘Greatest Hits’ episode of Getting to Aha!, host Darshan Mehta is joined by Shalini Joshi Yamdagni, Chronic Pain Relief Expert at EFT Thailand. Join them as they explore helping people with chronic pain find relief through alternative approaches, the power of emotions in influencing physical wellbeing, and the use of Emotional Freedom Techn…
  continue reading
 
Darshan explains why you shouldn’t Trust Celebrities When Choosing Your Drugs! Hidden Agendas: They're paid to promote, not give unbiased advice. Not Medical Experts: Trust your doctor's knowledge, not a celebrity's opinion. Oversimplified Info: 30-second ads can't tell the whole story. Not Personalized: Your doctor can give you the right advice fo…
  continue reading
 
Recent pharmacy walkouts and closures at major chains highlight a critical issue: staffing shortages. Independent pharmacies are also at risk. Here are 5 tips for pharmacy owners and managers to prepare for potential temporary closures: Cross-Train Staff: Train front-end staff on basic pharmacy procedures (depending on state regulations) so they ca…
  continue reading
 
In this episode of Getting to Aha!, Darshan Mehta is joined by Heath Tredell, the Managing Director of Bablake House Limited. Join them as they discuss formative Aha! moments, retiring early, and prioritizing experiences over possessions. Heath Tredell is the Managing Director of Bablake House Limited, a family-owned residential home that offers ho…
  continue reading
 
We dive deep into 5 uses of Ozempic, a drug known for managing diabetes, but with surprising potential beyond! Here are 5 intriguing uses you might not have heard of: Liver Support: Early research suggests Ozempic could benefit liver health, but more studies are needed. Weight Loss Weapon: Ozempic has a weight-loss version, offering a powerful tool…
  continue reading
 
In today's episode, we discuss AI-generated content in the pharmaceutical industry. AI has revolutionized content creation, but it's not without its legal and ethical dilemmas. Take, for instance, the New York Times' lawsuit against OpenAI, highlighting the contentious issue of data ownership. As pharma companies increasingly rely on AI for content…
  continue reading
 
In today’s short, Darshan discusses why drugs cost so much. It takes around 10 to 15 years and roughly $2.3 billion to bring a drug to market. That means a drug company spends between $420,000 and $630,000 daily during this process. Imagine going to a casino every day, betting that much money without knowing the outcome, for 10 to 15 years. What ki…
  continue reading
 
In this ‘Greatest Hits’ episode of Getting to Aha!, host Darshan Mehta is joined by Prateek Panda, VP of Marketing at Phyllo. join them as they explore the importance of customer insights, the importance of authenticity, and the future of the industry. Prateek also shares valuable insights and advice for businesses looking to leverage influencers f…
  continue reading
 
Loading …

Hurtigreferanseguide

Copyright 2024 | Sitemap | Personvern | Vilkår for bruk | | opphavsrett